@prefix epid: .
@prefix dc: .
@prefix geo: .
@prefix bibo: .
@prefix owl: .
@prefix void: .
@prefix event: .
@prefix skos: .
@prefix xsd: .
@prefix cc: .
@prefix ep: .
@prefix foaf: .
@prefix rdf: .
@prefix rdfs: .
@prefix eprel: .
@prefix dct: .
<>
foaf:primaryTopic ;
rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .
dc:format "text/html";
dc:title "HTML Summary of #3223 \n\nStrategic design and optimization of Umifenovir analogues: Balancing antiviral efficacy and hERG toxicity against SARS-CoV-2\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 ;
rdf:_3 ;
rdf:_4 ;
rdf:_5 ;
rdf:_6 ;
rdf:_7 ;
rdf:_8 ;
rdf:_9 ;
rdf:_10 ;
rdf:_11 ;
rdf:_12 ;
rdf:_13 ;
rdf:_14 ;
rdf:_15 ;
rdf:_16 ;
rdf:_17 .
bibo:abstract "Arbidol (ARB, Umifenovir), a broad-spectrum antiviral from Russia, lacks Food and Drug Administration (FDA) approval due to insufficient clinical data and undocumented toxicity concerns. Its indole scaffold, with six unique substitutions, enables optimization for improved efficacy. This study optimized ARB's antiviral potency and safety by modifying the N1, C2, C3, and C4 positions. Antiviral efficacy was evaluated in SARS-CoV-2-infected VERO E6 cells, while optimization was guided by absorption, distribution, metabolism, and excretion (ADME), in vivo pharmacokinetic (PK) and hERG. Early modifications at N1 and C2 produced compounds 10 and 14 (IC50 = 1.5 μM), surpassing ARB (IC50 = 9.0 μM). Further refinements yielded compounds 42 (IC50 = 1.1 μM) and 56 (IC50 = 0.24 μM), resolving hERG toxicity (>30 μM). C3 modifications led to lead compounds 77, 79, and 81 (IC50 = 0.67-0.7 μM), achieving superior potency while eliminating hERG toxicity. Mechanism of entry inhibition and immunofluorescence confirmed compound 77 significantly reduced SARS-CoV-2 within Vero cells, supporting their preclinical potential."^^xsd:string;
bibo:authorList ;
bibo:issue "9";
bibo:volume "68";
dct:creator ,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
;
dct:date "2025-05";
dct:isPartOf ,
;
dct:publisher ;
dct:title "Strategic design and optimization of Umifenovir analogues: Balancing antiviral efficacy and hERG toxicity against SARS-CoV-2"^^xsd:string;
rdf:type bibo:AcademicArticle,
bibo:Article,
ep:ArticleEPrint,
ep:EPrint;
rdfs:seeAlso .
foaf:name "American Chemical Society (ACS)"^^xsd:string;
rdf:type foaf:Organization .
foaf:familyName "Patra"^^xsd:string;
foaf:givenName "Binita"^^xsd:string;
foaf:name "Binita Patra"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Singh Chawla"^^xsd:string;
foaf:givenName "Ravneet"^^xsd:string;
foaf:name "Ravneet Singh Chawla"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Das"^^xsd:string;
foaf:givenName "Dipankar"^^xsd:string;
foaf:name "Dipankar Das"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Talukdar"^^xsd:string;
foaf:givenName "Arindam"^^xsd:string;
foaf:name "Arindam Talukdar"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Bokara"^^xsd:string;
foaf:givenName "Kiran Kumar"^^xsd:string;
foaf:name "Kiran Kumar Bokara"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Hoque"^^xsd:string;
foaf:givenName "Israful"^^xsd:string;
foaf:name "Israful Hoque"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Das"^^xsd:string;
foaf:givenName "Satyajeet"^^xsd:string;
foaf:name "Satyajeet Das"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Devi"^^xsd:string;
foaf:givenName "Renuga"^^xsd:string;
foaf:name "Renuga Devi"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Ghosh Dastidar"^^xsd:string;
foaf:givenName "Uddipta"^^xsd:string;
foaf:name "Uddipta Ghosh Dastidar"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Joshi"^^xsd:string;
foaf:givenName "Akshay"^^xsd:string;
foaf:name "Akshay Joshi"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Singh"^^xsd:string;
foaf:givenName "Nittu"^^xsd:string;
foaf:name "Nittu Singh"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Ringe"^^xsd:string;
foaf:givenName "Rajesh P"^^xsd:string;
foaf:name "Rajesh P Ringe"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Martin"^^xsd:string;
foaf:givenName "Alna Kuriyickal"^^xsd:string;
foaf:name "Alna Kuriyickal Martin"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Kumar"^^xsd:string;
foaf:givenName "Sahil"^^xsd:string;
foaf:name "Sahil Kumar"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Thakur"^^xsd:string;
foaf:givenName "Krishan Gopal"^^xsd:string;
foaf:name "Krishan Gopal Thakur"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Das"^^xsd:string;
foaf:givenName "Nirmal"^^xsd:string;
foaf:name "Nirmal Das"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Sardana"^^xsd:string;
foaf:givenName "Yogesh"^^xsd:string;
foaf:name "Yogesh Sardana"^^xsd:string;
rdf:type foaf:Person .
foaf:name "J. Med. Chem."^^xsd:string;
rdf:type bibo:Collection .